Higher sensitivity is not the whole story
The MSX offers higher sensitivity, but more signal does not automatically mean meaningfully lower detection limits. If your Q already meets your method requirements, the practical gain may be limited.
Thermo Fisher Scientific has announced End of Guaranteed Support (EOGS) and Retirement dates for the iCAP Q. Ionflight helps you decide what comes next — with engineers who service iCAP Q systems, access to critical parts, bench repair, preventive maintenance and service contracts. Keep a productive instrument running with a plan, or know when replacement is the smarter move.
A replacement decision is about more than product generation. The important questions are whether your iCAP Q still meets the work your lab needs to do, whether the support risk is manageable and when a planned move would create more value than continued operation.
The MSX offers higher sensitivity, but more signal does not automatically mean meaningfully lower detection limits. If your Q already meets your method requirements, the practical gain may be limited.
The MSX standardizes newer workflow and productivity capabilities. Many of those capabilities can also be configured or added to an iCAP Q, depending on the lab and application.
The iCAP Q is approaching EOGS and Retirement; the MSX is the current platform. Parts, serviceability and capital timing should be weighed alongside analytical performance.
A new MSX is approximately $200K–$250K. The question is whether the analytical, productivity and lifecycle benefits justify that investment for the work your lab actually performs.
| Consideration | iCAP Q | iCAP MSX | What it means |
|---|---|---|---|
| Core platform | Single-quadrupole ICP-MS | Single-quadrupole ICP-MS | The replacement decision is not a move to a fundamentally different analyzer class. |
| Sensitivity | Established iCAP Q performance | Higher sensitivity | More signal can provide analytical headroom, but sensitivity alone does not determine practical detection limits. |
| Detection limits | Meets established Q specifications | Similar for many major elements | If current methods are already comfortably within required limits, the analytical benefit of replacement may be modest. |
| Productivity & automation | Capabilities available through configuration and options | More capabilities standardized and integrated | The MSX may simplify routine workflows, but the value depends on what your lab actually needs. |
| High-matrix handling | Supported through appropriate interface/configuration strategies | Greater integration around high-matrix workflows | This can be a meaningful advantage for labs routinely handling demanding high-TDS samples. |
| Maintenance & monitoring | Established diagnostics and maintenance approach | Newer monitoring and maintenance features | Operational convenience may improve, but the value should be weighed against current Q reliability and serviceability. |
| Lifecycle position | EOGS begins Sept. 30, 2027; Retirement Sept. 30, 2028 | Current platform | Long-term supportability is the clearest structural reason to plan ahead. |
| Capital investment | Existing asset | Approx. $200K–$250K replacement | Replacement should create enough analytical, operational or risk-reduction value to justify the investment. |
The goal is not to keep every iCAP Q forever. It is to keep uncertainty from making the decision for you.
Review your iCAP Q optionsFor many labs, the real risk is not today's performance. It is the possibility that a board or major component failure could force a rushed capital purchase.
Ionflight sources and stocks electronic boards and major components for iCAP Q systems. The iCAP Q lifecycle review turns that capability into an instrument-specific continuity plan.
Ionflight has the technical expertise, repair capabilities and established resources required to keep iCAP Q systems operational beyond Thermo’s Retirement date. Our support model is not limited to drawing from a diminishing stock of used parts. We can diagnose and repair board-level faults, restore critical components and provide qualified replacement solutions when needed.
What is stocked, routinely sourced or already known to be long-lead.
What can be diagnosed, bench-repaired, sourced or replaced through a defined route.
What is worth staging based on lead time, failure risk and the cost of downtime.
Which component, software or condition issue would genuinely limit continued use.
The result: a clear parts continuity picture for your instrument.
See what the lifecycle review covers →Ionflight has serviced Thermo Scientific ICP-MS systems since 2002. That specialist experience supports iCAP Q owners with on-site service, bench repair, parts, preventive maintenance, technical support and service contracts.
Engineer-led troubleshooting, repair and return-to-performance work in the lab.
Component diagnostics and board-level repair paths where appropriate.
Condition- and usage-informed service designed to find risk before failure.
Remote expertise for diagnostics, performance questions and next-step planning.
Routine supply, critical-component planning and instrument-specific availability guidance.
Coverage options that bring support, maintenance, response and parts into one plan.
A good review can support either decision. The value is knowing why — and acting before downtime makes the choice for you.
The right outcome may be extend, monitor or replace. The point is to make that choice with evidence.
Use the downloadable guide to organize what EOGS and Retirement mean, parts and service considerations, and the questions to think through before extending or replacing.
An iCAP Q Lifecycle Review brings the condition of your instrument, parts availability, repair options, maintenance needs, software considerations and replacement timing into one conversation — so you can decide whether to extend, monitor or plan a replacement.
Request an iCAP Q Lifecycle Review and give our team a little context about your instrument. We will review the information before following up so the conversation can focus on your support options, lifecycle risks and the right next step.